CoChat

Rebaudioside A/TPGS mixed nanomicelles as promising nanocarriers for nimodipine ocular delivery

Li, Xuefei, Fang, Jingwang, Xin, Meng, Li, Qiqi, Wang, Jun, Yang, Hui, Wu, Xianggen · 2021 · Drug Delivery and Translational Research

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Abstract

Nimodipine (NMD), a calcium channel blocker, has demonstrated benefits in treating glaucoma. However, its ocular therapeutic application remains limited due to its poor aqueous solubility, which restrains the development of an ophthalmic formulation. Thus, the present study aimed to formulate an NMD micelle ophthalmic solution to enhance the potential of NMD in an ocular topical formulation to treat glaucoma. The NMD micelle ophthalmic solution was formulated with nanocarriers composed of rebaudioside A and D-α-tocopheryl polyethylene glycol 1000 succinate. Spherical mixed micelles were optimized and obtained at a small micelle size 13.429 ± 0.181 nm with a narrow size distribution (polydispersity index 0.166 ± 0.023) and high encapsulation efficiency rate (99.59 ± 0.09%). Compared with free NMD, NMD in micelles had much greater in vitro membrane permeability and antioxidant activity. The NMD micelle ophthalmic solution was well tolerated in rabbit eyes. It profoundly improved the in vivo intraocular permeation of NMD, and in vivo intraocular pressure reduction and improved miosis were also observed. Accordingly, this NMD micelle ophthalmic solution might be a promising ocular formulation to treat glaucoma. Graphical abstract.

Overview

Integrity signals

Registry

Crossref · 10.1007/s13346-020-00834-0

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 57 references

Cited by

See all 27

Metadata

Authors
Li, X., Fang, J., Xin, M., Li, Q., Wang, J., Yang, H., & Wu, X.
Affiliations
  • Qingdao University of Science and Technology (CN)
  • Qingdao University (CN)
  • Binzhou Medical University (CN)
Corresponding author
Wu, Xianggen
Venue
Drug Delivery and Translational Research
Published
2020-08-11
Volume
11
Issue
3
Pages
1119-1132
ISSN
  • 2190-393X (ISSN-L)
  • 2190-3948
OpenAlex
W3048481911
Cited by
27
References
57
Citations by year
2026: 3 · 2025: 3 · 2024: 7 · 2023: 9 · 2022: 3 · 2021: 1 · 2020: 1
FWCI
1.36
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Drug Delivery and Translational Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (81770895)
  • Key Technology Research and Development Program of Shandong (2019GSF108027)
  • Talent Fund of Shandong Collaborative Innovation Center of Eco-Chemical Engineering (XTCXQN19)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Keywords
nimodipine, rebaudioside A, TPGS, mixed micelles, ocular drug delivery, glaucoma, calcium channel blockers, ophthalmic preparations, intraocular pressure, miosis, membrane permeability, antioxidant activity, ocular tolerance
MeSH terms
Animals, Cornea, Drug Carriers, Micelles, Nimodipine, Polyethylene Glycols, Rabbits, Vitamin E, Diterpenes, Kaurane, Administration, Ophthalmic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rebaudioside A/TPGS mixed nanomicelles as promising nanocarriers for nimodipine ocular delivery. https://app.cochat.ai/papers/10.1007/s13346-020-00834-0
The paper
Li, X., Fang, J., Xin, M., Li, Q., Wang, J., Yang, H., & Wu, X. (2021). Rebaudioside A/TPGS mixed nanomicelles as promising nanocarriers for nimodipine ocular delivery. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-020-00834-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.